Teleflex | TFX - Selling And Administration Expenses

Stock Price
107.32
Daily Change
-0.94 -0.87%
Monthly
1.38%
Yearly
-22.11%
Q1 Forecast
104.08

Teleflex reported $222.37M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Abbott USD 3.13B 125M Dec/2025
Align Technology USD 441.68M 23.88M Dec/2025
AngioDynamics USD 35.99M 14K Feb/2025
AtriCure USD 78.34M 109K Dec/2025
Avanos Medical USD 78.8M 1.2M Dec/2025
Baxter International USD 761M 53M Dec/2025
Becton, Dickinson and Co. USD 1.39B 27M Dec/2025
Boston Scientific USD 1.83B 93M Dec/2025
Cooper Companies USD 373.1M 46.1M Dec/2025
Dexcom USD 299.9M 31.5M Dec/2025
Edwards Lifesciences USD 602.9M 88.3M Dec/2025
General Electric Aerospace USD 1.58B 385M Dec/2025
Globus Medical USD 318.48M 4.88M Dec/2025
Haemonetics USD 109.15M 7.54M Dec/2025
Hologic USD 2.5B 2.24B Dec/2025
Inogen USD 43.77M 510K Jun/2024
Insulet USD 331.4M 16.2M Dec/2025
Integra LifeSciences USD 156.45M 12.6M Dec/2025
Intuitive Surgical USD 687.1M 113.8M Dec/2025
J&J USD 6.75B 831M Dec/2025
Masimo USD 128M 11.6M Dec/2025
Medtronic 2.97B 159M Sep/2025
Merit Medical Systems USD 114.83M 7.45M Dec/2025
Orthofix International USD 112.21M 1.1M Sep/2024
ResMed USD 278.4M 19.2M Dec/2025
Steris USD 352.3M 2.6M Dec/2025
Stryker USD 2.14B 150M Dec/2025
Tandem Diabetes Care USD 99.86M 5.34M Dec/2025
Teleflex USD 222.37M 59.4M Dec/2025
Zimmer Biomet Holdings USD 855.7M 44.3M Dec/2025